The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Treatment patterns in multiple myeloma: Real-world experience of the triple-class exposed (TCE) patient.
 
Nina Shah
Stock and Other Ownership Interests - Indapta Therapeutics
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Genentech/Abbvie; Indapta Therapeutics; Karyopharm Therapeutics; Nektar; Nkarta; Oncopeptides; Precision Biosciences; Sanofi; Seagen; Surface Oncology; TeneoBio
Research Funding - Bluebird Bio; Celgene; Janssen; Sutter Medical Group
 
Concetta Crivera
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
Research Funding - Johnson & Johnson
Other Relationship - Johnson & Johnson
 
Maneesha Mehra
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Iman Mohammadi
Employment - Avalere Health
Research Funding - Janssen Scientific Affairs (Inst)
 
Karl M. Kilgore
Employment - Avalere Health
Research Funding - Janssen Scientific Affairs (Inst)
 
Anny C. Wong
Employment - Avalere Health
Research Funding - Janssen Scientific Affairs (Inst)
 
Sundar Jagannath
Honoraria - Celgene; Karyopharm Therapeutics
Consulting or Advisory Role - Bristol-Myers Squibb; Celgene; Janssen; Karyopharm Therapeutics; Novartis
Research Funding - Bristol-Myers Squibb (Inst); celgene (Inst); Karyopharm Therapeutics (Inst)